Chester A H, Martin G R, Bodelsson M, Arneklo-Nobin B, Tadjkarimi S, Tornebrandt K, Yacoub M H
National Heart and Lung Institute, Harefield Hospital, Middlesex, United Kingdom.
Cardiovasc Res. 1990 Nov;24(11):932-7. doi: 10.1093/cvr/24.11.932.
The aim of the study was to investigate the receptor events that mediate the vascular effects of 5-hydroxytryptamine (5-HT) on human coronary arteries, since 5-HT has long been thought to play a role in coronary artery vasospasm.
Recently available selective receptor agonists and antagonists were used to examine the 5-HT receptor subtypes present in human epicardial coronary arteries using in vitro organ baths.
138 segments of coronary arteries were obtained from 21 patients aged 2-66 years undergoing heart transplantation.
5-HT produced only concentration dependent contractions of coronary artery segments. No evidence was obtained for 5-HT receptors mediating either endothelium dependent or endothelium independent vasorelaxation. In tissue from patients without ischaemic heart disease, 5-HT effects were mimicked by (+/-)-alpha-methyl-5-HT (alpha-me-5-HT), a selective agonist at 5-HT2 receptors. In addition, the selective 5-HT1-like receptor agonist GR43175 produced contractions which achieved 30% of the maximum response to 5-HT. Responses to alpha-me-5-HT were surmountably antagonised by the non-selective antagonist methiothepin (0.1 mumol.litre-1) as well as the 5-HT2 receptor antagonist ketanserin (0.1 mumol.litre-1). In contrast GR43175 effects were resistant to blockade by ketanserin, but remained sensitive to methiothepin. Responses to the two agonists were not antagonised by the 5-HT3 receptor antagonist MDL72222 (1.0 mumol.litre-1). Vessel segments from ischaemic heart disease patients also contracted to alpha-me-5-HT and GR43175. Diseased arteries contracted with a decrease in the maximal response induced by both alpha-me-5-HT and by 90 mM K+ depolarisation compared to "normal" vessels, but the effect of GR43175 was preserved in the diseased arteries. Vascular rings adjacent to an atheromatous lesion were more reactive to GR43175 than serial segments taken distal to the lesion.
These results show that both 5-HT1-like and 5-HT2 receptors mediate contraction of human epicardial coronary arteries and indicate that effects mediated by 5-HT1-like receptors but not 5-HT2 receptors are preserved in patients with ischaemic heart disease.
本研究旨在探讨介导5-羟色胺(5-HT)对人冠状动脉血管效应的受体事件,因为长期以来人们一直认为5-HT在冠状动脉痉挛中起作用。
使用最近可得的选择性受体激动剂和拮抗剂,通过体外器官浴来检测人冠状动脉心外膜中存在的5-HT受体亚型。
从21例年龄在2至66岁接受心脏移植的患者中获取138段冠状动脉。
5-HT仅使冠状动脉节段产生浓度依赖性收缩。未获得5-HT受体介导内皮依赖性或非内皮依赖性血管舒张的证据。在无缺血性心脏病患者的组织中,5-HT的作用可被(±)-α-甲基-5-HT(α-me-5-HT)模拟,α-me-5-HT是一种5-HT2受体选择性激动剂。此外,选择性5-HT1样受体激动剂GR43175也可产生收缩作用,其收缩幅度可达5-HT最大反应的30%。对α-me-5-HT的反应可被非选择性拮抗剂美噻吨(0.1μmol·L-1)以及5-HT2受体拮抗剂酮色林(0.1μmol·L-1)竞争性拮抗。相比之下,GR43175的作用对酮色林的阻断具有抗性,但对美噻吨仍敏感。5-HT3受体拮抗剂MDL72222(1.0μmol·L-1)对这两种激动剂的反应均无拮抗作用。缺血性心脏病患者的血管节段对α-me-5-HT和GR43175也有收缩反应。与“正常”血管相比,病变动脉对α-me-5-HT和90 mM K+去极化诱导的最大反应均降低,但GR43175在病变动脉中的作用仍然存在。与病变远端的连续节段相比,靠近动脉粥样硬化病变的血管环对GR43175的反应更强。
这些结果表明,5-HT1样受体和5-HT2受体均介导人冠状动脉心外膜的收缩,并表明在缺血性心脏病患者中,由5-HT1样受体而非5-HT2受体介导的效应仍然存在。